Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2025-12-24 @ 11:00 PM
Study NCT ID:
NCT04134169
Status:
RECRUITING
Last Update Posted:
2022-10-10
First Post:
2019-10-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)
Sponsor:
Kang Stem Biotech Co., Ltd.
Organization:
Study Overview
Official Title:
A Multi-center, Open, Long-term Follow-up Study to Evaluate the Efficacy and Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis : 5-year Results From the K0202 Extension Study
Status:
RECRUITING
Status Verified Date:
2022-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)
Detailed Description:
A Multi-center, Open, Long-term Follow-up Study to Evaluate the Efficacy and Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid arthritis: 5-year Results From the K0202 Extension Study
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: